Join to View Full Profile
200 Bank of America# 365Los Angeles, CA 90074
Phone+1 310-825-6301
Dr. Lin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Diego) Medical CenterFellowship, Rheumatology, 2000 - 2003
Scripps Clinic/Scripps Green HospitalFellowship, Allergy and Immunology, 1999 - 2002
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1997 - 1999
Johns Hopkins University School of MedicineClass of 1995
Certifications & Licensure
CA State Medical License 1999 - 2025
NY State Medical License 2002 - 2025
TX State Medical License 1997 - 2025
Publications & Presentations
PubMed
- 271 citationsA Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease.Stephan R. Targan, Brian G. Feagan, Severine Vermeire, Remo Panaccione, Gil Y. Melmed
The American Journal of Gastroenterology. 2016-08-02 - 57 citationsA Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab in Subjects with Rheumatoid Arthritis and an Inadequate Response to MethotrexateKarel Pavelka, Yun Chon, Richard Newmark, Shao-Lee Lin, Scott Baumgartner
The Journal of Rheumatology. 2015-04-15 - 37 citationsClinical trial safety and mortality analyses in patients receiving etanercept across approved indicationsAlice B. Gottlieb, Kenneth B. Gordon, Edward H. Giannini, Philip J. Mease, Juan Li
Journal of Drugs in Dermatology. 2011-03-01
Press Mentions
ACELYRIN Acquires ValenzaBio, Strengthens Immunology PositionJanuary 6th, 2023
Integrated Clinical Trial Analyses Further Substantiate That Teprotumumab Significantly Improves Debilitating Effects of Thyroid Eye Disease, Including Eye Bulging, Double Vision and Quality of LifeOctober 31st, 2019
American Journal of Ophthalmology (AJO) Publishes Review Highlighting Lack of Treatments for Active Thyroid Eye Disease (TED)August 19th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
